Skip to main content

Hypercholesterolemia as one of the risk factors of intracerebral hemorrhage

Abstract

Stroke is still a major cause of morbidity and mortality throughout the world, although better stratification and treatment modalities are being developed. As compared to ischemic stroke, intracerebral hemorrhage (ICH) possesses many unknown data and lacks guidelines for better prophylaxis. In this study, we aimed to investigate patients with ICH hospitalized in our neurology department within 5 years in terms of risk stratification. A total of 4,449 patients were hospitalized; 1,378 of patients (31 %) were diagnosed as having cerebrovascular disease and of these 165 patients (3.7 %) had ICH. The risk factors of patients with ICH were investigated and compared with age- and gender matched 75 healthy subjects. We observed that hypercholesterolemia (p = 0.002) was one of the most common risk factors in patients with ICH as compared to controls, together with hypertension (p = 0.010). On the other hand, hypolipidemia (LDL-cholesterol level < 50 mg/dl) was not present in any of the patients. As our purpose as neurologists is to reduce the occurrence and fatal outcome of cerebrovascular events, we aimed to emphasize the importance of risk factors to be well defined, for which every effort should be exhibited for both primary and secondary prevention.

This is a preview of subscription content, access via your institution.

References

  1. Carhuopama JR, Mayer SA, Hanley DF (2010) Intracerebral Hemorrhage. The epidemiology of intracerebral hemorrhage. Cambridge University Press, Cambridge, pp 1–15

    Google Scholar 

  2. Kase CS, Mohr JP, Caplan LR (2004) Stroke: pathophysiology, diagnosis, and management risk. Intracerebral Hemorrhage 13:327–376

    Google Scholar 

  3. Bejot Y, Osseby GV, Gremeaux V, Durier J, Rouaud O, Moreau T, Giroud M (2009) Changes in risk factors and preventive treatments by stroke subtypes over 20 years: a population-based study. J Neurol Sci 287:84–88

    PubMed  Article  Google Scholar 

  4. Siracuse JJ, Robich MP, Gautam S, Kasper EM, Moorman DW, Hauser CJ (2010) Antiplatelet agents, warfarin, and epidemic intracranial hemorrhage. Surgery 148:724–730

    PubMed  Article  Google Scholar 

  5. Nago N, Ishikawa S, Goto T, Kayaba K (2011) Low cholesterol is associated with mortality from stroke, heart disease, and cancer: the Jichi Medical School cohort study. J Epidemiol 21:67–74

    PubMed  Article  Google Scholar 

  6. Suzuki K, Izumi M, Sakamato T, Hayashi M (2011) Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Cerebrovasc Dis 31:100–106

    PubMed  Article  CAS  Google Scholar 

  7. Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth WT Jr, Psaty BM (2004) Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 63:1868–1875

    PubMed  Article  CAS  Google Scholar 

  8. Tveiten A, Ljostad U, Mygland A, Thomassen L, Pripp AH, Naes H (2012) Intracerebral hemorrhage in Southern Norway—a hospital-based incidence study. Eur Neurol 67:240–245

    PubMed  Article  Google Scholar 

  9. Kim YZ, Park YH, Song YG, Kim KH (2012) Clinical analysis of factors predisposing the recurrence of primary intracerebral hemorrhage in patients taking anti-hypertensive drugs: a prospective cohort study. Clin Neurol Neurosurg 3033:1–9

    Google Scholar 

  10. Soo YOY, Siu DYW, Abrigo J, Yu S, Ng N, Ahuja AT, Wong LKS, Leung TW (2012) Risk of intracerebral hemorrhage in patients with cerebral microbleeds undergoing endovascular intervention. Stroke 43:1532–1536

    PubMed  Article  Google Scholar 

  11. Hankey GJ, Wong KSL, Chankrachang S, Chen C, Crimmins D, Frayne J, Kim JS, Li Y, Liou CW, Merican JS, Misbach J, Navarro J, Shinohara Y, Wang Y, Yoon BW (2010) Management of cholesterol to reduce the burden of stroke in Asia: consensus statement. Int J Stroke 5:209–216

    PubMed  Article  Google Scholar 

  12. Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G (2012) Total and high-density lipoprotein cholesterol and stroke risk. Stroke 43:1768–1774

    PubMed  Article  Google Scholar 

  13. Ikram MA, Wieberdink RG, Koudstaal PJ (2012) International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep 14:300–306

    Google Scholar 

  14. Goldstein LB, Amarenco P, Zivin J, Messig M, Altafullah I, Callahan A, Hennerici M, Mac Leod MJ, Sillesen H, Zweifler R, Michael K, Welch A, Behalf of SPARCL Investigators (2009) Statin treatment and stroke outcome in the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke 40:3526–3531

    PubMed  Article  CAS  Google Scholar 

  15. LaRosa JC, Pedersen TR, Somaratne R, Wasserman SM (2013) Safety and effect of very low levels of low density lipoprotein cholesterol on cardiovascular events. Am J Cardiol 111:1221–1229

    PubMed  Article  CAS  Google Scholar 

  16. Collins R, Armitage J, Parish S, Sleight P, Peto R (2004) Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 363:757–767

    PubMed  Article  Google Scholar 

  17. Ramjee V, Jacobson TA (2011) Intensifying statin therapy to maximize cardiovascular risk reduction: is 50 the new 70? goals are getting old. Clin Lipidol 6:131–136

    Article  CAS  Google Scholar 

  18. Oguz A, Temizhan A, Gulec S, Altuntas Y, Karsıdag K, Akalın AAK, Calık BT, Imeryuz N (2011) Dyslipidemia rates in age group 35–70 in Turkey. Obes Rev 7:581–582

    Google Scholar 

  19. Abacı (2011) The current status of cardiovascular risk factors in Turkey. Arch Turk Soc Cardiol 39 (Suppl 4):1–5

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mecbure Nalbantoglu.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bozluolcay, M., Nalbantoglu, M., Gozubatik-Celik, R.G. et al. Hypercholesterolemia as one of the risk factors of intracerebral hemorrhage. Acta Neurol Belg 113, 459–462 (2013). https://doi.org/10.1007/s13760-013-0222-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-013-0222-6

Keywords

  • Intracerebral hemorrhage
  • Hypercholesterolemia
  • Risk factors